Related Experiment Videos
T cells and aging (update february 1999)
G Pawelec1, R B Effros, C Caruso
1University of Tubingen, Tubingen, FRG. graham.pawelec@med.uni-tuebingen.de
Frontiers in Bioscience : a Journal and Virtual Library
|March 3, 1999
Summary
Aging weakens the immune system (immunosenescence), increasing disease risk in older adults. This review explores factors like T cell dysfunction contributing to age-related immune decline.
Area of Science:
- Immunology
- Gerontology
- Cellular Biology
Background:
- Immune system decline with aging, termed immunosenescence, is linked to increased infections, autoimmunity, and cancer in the elderly.
- T cell function dysregulation is a key factor in age-related immune deterioration.
- Understanding immunosenescence is crucial for addressing age-related health challenges.
Purpose of the Study:
- To review the scientific basis of factors contributing to T cell immunosenescence.
- To discuss the potential clinical relevance of these factors in aging populations.
- To consolidate current knowledge on immunosenescence mechanisms.
Main Methods:
- Literature review of scientific studies on immunosenescence.
- Analysis of factors affecting T cell function in aging.
- Synthesis of data on stem cell defects, thymus involution, and immune cell aging.
- Examination of disrupted activation pathways and replicative senescence.
Main Results:
- Identified key factors in T cell immunosenescence including stem cell defects, thymus involution, and aging of immune cells.
- Highlighted the role of antigen-presenting cell defects and disrupted immune cell activation pathways.
- Discussed replicative senescence of clonally expanding cells as a contributor.
- Emphasized the complex interplay of these factors in immune system aging.
Conclusions:
- Immunosenescence is a multifactorial process significantly impacting health in older adults.
- T cell dysfunction is central to immunosenescence, driven by various cellular and molecular changes.
- Further research into these factors is essential for developing interventions to mitigate age-related immune decline and associated diseases.